2014
DOI: 10.1159/000357991
|View full text |Cite
|
Sign up to set email alerts
|

Donor Hemovigilance during Preparatory Plasmapheresis

Abstract: Background: Reports on unexpected donor events (UEs) during preparatory plasmapheresis (PPP) are scarce, and rarely consider technical UEs. Methods: Defined local and systemic UEs were graded by severity; technical UEs were not graded. On January 1, 2008, E.B.P.S.-Logistics (EBPS) installed the UE module for plasma management software (PMS). Donor room physicians entered UEs daily into the PMS. Medical directors reviewed entries quarterly. EBPS compiled data on donors, donations and UEs from January 1, 2008 to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
16
1
9

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(29 citation statements)
references
References 45 publications
3
16
1
9
Order By: Relevance
“…Our catalogue of local and systemic UEs corresponds to that established in the literature for BDs [5,21,24]. Applying EMA criteria for frequency of adverse drug reactions [25] to donor hemovigilance, overall local, systemic and technical UEs as defined here were commonly associated with BD (2.4%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our catalogue of local and systemic UEs corresponds to that established in the literature for BDs [5,21,24]. Applying EMA criteria for frequency of adverse drug reactions [25] to donor hemovigilance, overall local, systemic and technical UEs as defined here were commonly associated with BD (2.4%).…”
Section: Discussionmentioning
confidence: 99%
“…Of course, one may look upon repeated venipunctures and failing to establish or maintain sufficient blood flow as part of local UEs. However, technical UEs have substantial economic implications as they contribute substantially to cost in terms of personnel time, supplies, and lost donors [24]. These aspects are simply not covered by the designating such UEs as ‘hematoma', and they are not primarily of concern to the donor.…”
Section: Discussionmentioning
confidence: 99%
“…As shown in table 1, the number of AEs reported in the context of haemapheresis varies by two log steps from 0.025% [9] to 5.77% and 6.55% [10,11]. One explanation for this wide range is that some authors included mild, clinically insignificant donor reactions (e.g., small haematomas, short vasovagal reactions without faint, mild paresthesia [11][12][13][14]), whereas other reports referred to moderate and severe adverse events (SAEs) [14][15][16] or to SAEs only [9,17]. But even within the donor reaction grading 'SAE', the results may vary by 10-fold between 0.025% [9] and 0.24% [13].…”
Section: Introductionmentioning
confidence: 99%